Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma

Conditions:   Uveal Melanoma;   Metastatic Cancer Interventions:   Drug: Cediranib Maleate;   Drug: Durvalumab Sponsors:   Grupo Español Multidisciplinar de Melanoma;   MFAR Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials